Literature DB >> 2397416

Ketamine blockade of spreading depression: rapid development of tolerance.

T Amemori1, J Bures.   

Abstract

Persistence of the ketamine-induced blockade of spreading depression (SD) was studied in 15 rats, anesthetized with 200 mg/kg ketamine followed at 50- to 60-min intervals by 3-5 injections of 100 mg/kg of the drug. Cortical or caudate SDs evoked 10 min after the first ketamine injection were blocked but the amplitude of SD waves elicited at regular 10-min intervals gradually increased while the blockade induced by subsequent ketamine injections weakened and became unrecognizable after the fifth injection. The result was not due to prolonged action of ketamine alone but rather to combined effect of ketamine and SD repetition. The development of tolerance is probably due to use-dependence of NMDA-gated channels which must be taken into account when assessing the therapeutic value of NMDA antagonists in treatment of brain ischemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2397416     DOI: 10.1016/0006-8993(90)90101-g

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  'Spreading depression of Leão' and its emerging relevance to acute brain injury in humans.

Authors:  Martin Lauritzen; Anthony J Strong
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  The use of spreading depression waves for acute and long-term monitoring of the penumbra zone of focal ischemic damage in rats.

Authors:  V I Koroleva; J Bures
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

3.  Systematic review of the pharmacological agents that have been tested against spreading depolarizations.

Authors:  Anna Klass; Renan Sánchez-Porras; Edgar Santos
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-20       Impact factor: 6.200

4.  Rapid development of tolerance to sub-anaesthetic dose of ketamine: an oculomotor study in macaque monkeys.

Authors:  Pierre Pouget; Nicolas Wattiez; Sophie Rivaud-Péchoux; Bertrand Gaymard
Journal:  Psychopharmacology (Berl)       Date:  2010-03-23       Impact factor: 4.530

5.  Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions.

Authors:  Leah Vines; Diana Sotelo; Allison Johnson; Evan Dennis; Peter Manza; Nora D Volkow; Gene-Jack Wang
Journal:  Intell Med       Date:  2022-03-07

6.  Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1.

Authors:  Katharina Eikermann-Haerter; Ergin Dileköz; Chiho Kudo; Sean I Savitz; Christian Waeber; Michael J Baum; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

Review 7.  Cortical spreading depression-induced preconditioning in the brain.

Authors:  Ping-Ping Shen; Shuai Hou; Di Ma; Ming-Ming Zhao; Ming-Qin Zhu; Jing-Dian Zhang; Liang-Shu Feng; Li Cui; Jia-Chun Feng
Journal:  Neural Regen Res       Date:  2016-11       Impact factor: 5.135

8.  The role of spreading depolarizations and electrographic seizures in early injury progression of the rat photothrombosis stroke model.

Authors:  Karl Schoknecht; Majed Kikhia; Coline L Lemale; Agustin Liotta; Svetlana Lublinsky; Susanne Mueller; Philipp Boehm-Sturm; Alon Friedman; Jens P Dreier
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-02       Impact factor: 6.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.